We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Tessenderlo Group | EU:TESB | Euronext | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 18.82 | 18.80 | 18.86 | 18.88 | 18.74 | 18.82 | 5,247 | 11:18:07 |
Brussels, April 30 2014
Regulated information[1] | Press release |
Million EUR | 1Q13 | 1Q14 | % Change |
Revenue group | 486.5 | 396.4 | -18.5% |
- Revenue Other segment | -133.2 | -29.8 | |
Revenue at comparable scope | 353.3 | 366.6 | 3.8% |
Rebitda group | 32.7 | 41.8 | 27.9% |
- Rebitda Other segment | -3.0 | -2.2 | |
Rebitda at comparable scope | 29.6 | 39.7 | 33.8% |
Net financial debt | 332.6 | 240.5 | - |
Notional net debt | 431.9 | 344.9 | - |
Comparable scope includes the following businesses:
Other segment includes the businesses sold or ended since January 2013: Compounds, Organic Chlorine Derivatives, Pharmaceutical Intermediates, Phosphates and Profiles.
1Q14 operating performance is better than expected, driven by the Agro segment and overall cost reductions. Despite this 1Q14 result, the full year 2014 rebitda is expected to be only slightly above the 2013 rebitda.
Revenue
At comparable scope, revenue of the 3 core segments Agro, Bio-valorization and Industrial solutions, grew in 1Q14 by 3.8%. Revenue is mostly driven by strong 1Q fertilizer volumes in Agro and the mild winter for Industrial solutions, partly offset by lower revenues in the Bio-valorization segment.
REBITDA
In addition to the solid top line results in Agro and Industrial solutions, the group is further benefiting from cost improvement initiatives. As anticipated, the rebitda of the Bio-valorization segment dropped against the higher 1Q13 comparative.
Net financial debt
At the end of March 2014, group net financial debt stood at 240.5 million EUR, versus 258.9 million EUR at the end of December 2013, resulting in a leverage of 1.9x at the end of 1Q14.
The decrease of the net financial debt is mostly driven by the higher operational results, while increased factoring allowed for keeping working capital approximately flat versus end 2013. Capital expenditure amounted to 14.1 million EUR in the first quarter versus 21.2 million EUR in 1Q13.
Outlook 2014
The Q1 results reflect a strong start of the year, being a combination of seasonality on the one hand, and overperformance versus expectations in the quarter on the other hand. Based on current assumptions, which still include low visibility in the fragile economic environment for the remainder of the year, Tessenderlo Group anticipates that the 2014 REBITDA will be slightly above the 2013 REBITDA, adjusted for entities sold since January 2013.
Financial calendar
Second quarter 2014 results | August 27, 2014 |
Third quarter 2014 trading update | October 29, 2014 |
Annual General Meeting of Shareholders | June 3, 2014 |
Tessenderlo Group is a worldwide specialty company, focused on food, agriculture, water management and on valorizing bio-residuals. The group employs about 5,000 people and is a leader in most of its markets, with a consolidated revenue of 1.8 billion EUR in 2013. Tessenderlo Chemie NV is listed on NYSE Eurolist by Euronext Brussels and is part of Next 150 and BEL Mid indices. Financial News wires: Bloomberg: TESB BB - Reuters: TesBt.BR - Datastream: B:Tes
Media and Investor Relations | Investor Relations |
Ingvild Van Lysebetten | Kurt Dejonckheere |
+32 2 639 19 27 | +32 2 639 18 41 |
This press release is available in Dutch and English on the corporate website www.tessenderlogroup.com - under 'News & Media'
[1] The enclosed information constitutes regulated information as defined in the Royal Decree of 14 November 2007 regarding the duties of issuers of financial instruments which have been admitted for trading on a regulated market.
1 Year Tessenderlo Chart |
1 Month Tessenderlo Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions